NovaBay Pharmaceuticals, Inc. - FORM 10-K - EX-32.2 - EXHIBIT 32.2 - March 23, 2017

Attached files

file filename
10-K - FORM 10-K - NovaBay Pharmaceuticals, Inc.nby20161231_10k.htm
EX-32.1 - EXHIBIT 32.1 - NovaBay Pharmaceuticals, Inc.ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - NovaBay Pharmaceuticals, Inc.ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - NovaBay Pharmaceuticals, Inc.ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - NovaBay Pharmaceuticals, Inc.ex23-1.htm
EX-10.7 - EXHIBIT 10.7 - NovaBay Pharmaceuticals, Inc.ex10-7.htm
EX-4.5 - EXHIBIT 4.5 - NovaBay Pharmaceuticals, Inc.ex4-5.htm
EX-4.3 - EXHIBIT 4.3 - NovaBay Pharmaceuticals, Inc.ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - NovaBay Pharmaceuticals, Inc.ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - NovaBay Pharmaceuticals, Inc.ex4-1.htm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of NovaBay Pharmaceuticals, Inc. (the Company) on Form 10-K for the fiscal year ended December 31, 2016 (the Report), I, Thomas J. Paulson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 23, 2017

 

/s/ Thomas J. Paulson

Thomas J. Paulson

Chief Financial Officer

 

This Certification is made solely for the purpose of 18 USC Section 1350, subject to the knowledge standard contained therein, and not for any other purpose.

NovaBay Pharmaceuticals, Inc. Reports